ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Spread of 'black fungus' adds to India's COVID woes

Modi calls disease 'new challenge' but drug shortage dims outlook

NEW DELHI -- Already grappling with a deadly second wave of the coronavirus, India is now faced with a new challenge: an alarming rise in cases of mucormycosis, a rare but potentially fatal infection also known as black fungus.

The fungal disease -- which the U.S. Centers for Disease Control and Prevention says has a fatality rate of 54% -- has been reported among several thousand people, mostly diabetics recovering or having recovered from COVID-19. Several Indian states have declared black fungus an epidemic, prompting calls for the national government to stockpile the drug used in its treatment.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more